viruses try understand cause damage common damage mechanisms differ ultimately organoids identify docking points receptors viruses gain entry cells critical testing potential antiviral drugs moving clinical trials patients second technique propelling use organoids genome engineering collection methods allows researchers alter cell genetic code organoids engineered incorporate mutations suspected causing disease enable researchers determine genetic defects actually lead illness investigators someday able evaluate repairing mutations generate healthy organoids work lead new treatments counteract mutations effects neuroscientists eager explore applications mini brain technology drug development technology assess new medications affect brain tissue desired ways obviating need animal testing saving costs drug development